Kenvue shares fall even as J&J spinoff beats estimates in first quarterly earnings since IPO

J&J still owns a 90% stake in Kenvue, meaning it can generally control the direction of the consumer health spinoff’s business for the time being.

...

Johnson & Johnson investors can soon swap their shares for Kenvue stock — here's what you need to know

2 days ago

Warning labels in the U.S. seem to be everywhere. Here's why they may be pointless

4 weeks ago

Johnson & Johnson to reduce its Kenvue stake by at least 80% through exchange offer

4 weeks ago

Jim Cramer talks about his 'favorite stock,' telling investors to buy some as we did last week

1 week ago

UBS says this stock is the 'best story' among U.S. large caps, sees more than 15% upside ahead

1 week ago